BioPharm International-04-01-2012

Optimizing Filtration Strategies

Burrill on Biotech

April 01, 2012

Better news about the global economy buoys life-sciences funding.

Features

April 01, 2012

Industry experts discuss the benefits and challenges of self-administration of injectable therapies.

Features

April 01, 2012

A technical rountable featuring Sartorius Stedim Biotech, Pall Life Sciences, 3M Purification, Asahi Kasei Bioprocess, and Bio-Rad Laboratories.

FDA has created a dedicated cadre of foreign drug investigators and established permanent offices worldwide.

Final Word

April 01, 2012

Rather than seeking a single indication for one large group, the orphan-drug approach segments the market for a drug more minutely.

Soaring opioid use creates challenges for new drug development and supply-chain control.

Manufacturing Best Practices

April 01, 2012

A closer look at elastomer changeout times provides one example of using industry knowledge to improve operations and cost.

The authors discuss the technology and guidance required to achieve good KM in a biopharmaceutical company.

Perspectives on Outsourcing

April 01, 2012

Recovery audits and other best practices in procurement can improve the bottom line.

Features

April 01, 2012

The authors describe a new assembly for bulk and final drug product filling operations.

Boot Camp Business Guide

April 01, 2012

BioPharm talks with Tarja Mottram, CEO of Action for Results, about key business considerations when starting out.

This month, we rewind to an article titled "Good Manufacturing Practices Training."

Guest Editorial

April 01, 2012

Collaboration can begin with a conversation.

Guest Editorial

April 01, 2012

The confluence of science, technology, and regulation will provide our industry with the guidance to move forward.